Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Heart and Vessels

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00380-003-0705-0PMID 14520482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys.

  2002cited by this paper
• [Hepatitis C virus infection in patients with non Hodgkin's lymphoma].

  2001cited by this paper
• Prevalence of Antibodies against Hepatitis C Virus in the Elderly: A Seroepidemiological Study in a Nursing Home and in an Open Population

  2000cited by this paper
• Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis.

  2000cited by this paper
• Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.

  2000cited by this paper
• Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends

  2000cited by this paper
• Hepatitis C virus infection in Western Europe.

  1999cited by this paper
• Apical hypertrophic cardiomyopathy and hepatitis C virus infection.

  1999cited by this paper
• Extrahepatic manifestations of HCV infection: facts and controversies.

  1999cited by this paper
• Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli.

  1999cited by this paper
• Prevalence of antibodies against hepatitis C virus in the adult German population.

  1999cited by this paper
• Epidemiology of Hepatitis C Virus in Japan

  1999cited by this paper
• Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells*

  1998cited by this paper
• Hepatitis C virus infection and heart diseases: a multicenter study in Japan.

  1998cited by this paper
• Chronic variant of myocarditis associated with hepatitis C virus infection.

  1997cited by this paper
• HEPATITIS C VIRUS ANTIBODY (ANTI‐HCV): PREVALENCE IN PSORIASIS

  1996cited by this paper
• Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C

  1996cited by this paper
• Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

  1996cited by this paper
• Sicca syndrome associated with hepatitis C virus infection.

  1996cited by this paper
• Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy.

  1996cited by this paper
• Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus

  1996cited by this paper
• Dilated cardiomyopathy associated with hepatitis C virus infection.

  1995cited by this paper
• Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.

  1995cited by this paper
• Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma

  1994cited by this paper
• Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

  1993cited by this paper
• Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis

  1992cited by this paper
• Epidemiologic Research: Principles and Quantitative Methods.

  1983cited by this paper
• Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients.

  1979cited by this paper
• Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

  1976cited by this paper

• Immune Mechanisms of Viral, Autoimmune, and Immune Checkpoint Inhibitor-Associated Myocarditis.

  2026cites this paper
• The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network.

  2023cites this paper
• Impact of Direct-Acting Antivirals (daas) on cardiovascular diseases in patients with chronic hepatitis C.

  2021cites this paper
• Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients

  2021cites this paper
• An overview of the immune mechanisms of viral myocarditis

  2020cites this paper
• OBSOLETE: Cardiohepatic Interactions

  2018cites this paper
• Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review

  2017cites this paper
• Extra Hepatic Manifestations of Liver Diseases

  2016cites this paper
• Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C and hepatitis B: findings from the Global Burden of Disease Study

  2016cites this paper
• Hepatitis C virus and myocardial dysfunction – possible association

  2016cites this paper
• [Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components].

  2016cites this paper
• Complications related to intraoperative transesophageal echocardiography in liver transplantation

  2015cites this paper
• Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study

  2013cites this paper
• Cardiac Involvement of Hepatitis B and C Virus Infection

  2013cites this paper
• Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update.

  2012cites this paper
• Viral Load and Genotype Matter in Hepatitis C Virus Related Heart Disease in Cirrhotic Patients

  2012cites this paper
• [Apical hypertrophic cardiomyopathy associated with HCV infection].

  2011cites this paper
• Global alert and response network for hepatitis C virus-derived heart diseases: A call to action

  2009cites this paper
• Prevalence of hepatitis C virus infection in patients with cardiomyopathy.

  2009cites this paper
• Systemic abnormalities in liver disease.

  2009cites this paper
• Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications.

  2008cites this paper
• Differential diagnosis of human hepatitis.

  2008cites this paper
• HLA‐DPβ chain may confer the susceptibility to hepatitis C virus‐associated hypertrophic cardiomyopathy

  2007cites this paper
• Heart Function and Myocardial Tissue Characterization in Patients with HCV Related Cirrhosis: Diastolic Dysfunction and Cardiac Hypertrophy

  2007cites this paper
• Role of hepatitis C virus in cardiomyopathies.

  2006cites this paper
• Electrocardiogram abnormalities in captive chimpanzees (Pan troglodytes).

  2006cites this paper
• Is hepatitis C virus a cause of idiopathic dilated cardiomyopathy? A systematic review of literature.

  2006cites this paper
• Pathophysiological characteristics and responsiveness to neurohormonal antagonism in idiopathic dilated cardiomyopathy patients with antihepatitis C virus antibody.

  2005cites this paper
• HCV infection and pericarditis: an extrahepatic manifestation?

  2005cites this paper
• Review article: hepatitis C virus infection and type‐2 diabetes mellitus in renal diseases and transplantation

  2005cites this paper
• The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.

  2005cites this paper
• Hepatitis C virus infection and cardiomyopathies.

  2005cites this paper
• Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents.

  2004cites this paper
• Cardiovascular diseases as major extrahepatic manifestations of hepatitis C virus infection: Leukocytes, not hepatocytes, are the targets of hepatitis C virus infection

  year unknowncites this paper